Chelsea Therapeutics International Ltd. (Nasdaq: CHTP) reported that its neurological disorder treatment Droxidopa demonstrated significant improvement in patients sending the stock price soaring 58 cents to $3.09.
Chelsea's Droxidopa Improves Patient Condition
October 01, 2009 at 13:26 PM EDT
